New designs for phase II trials: application to a trial of targeted therapies vs. chemotherapy in patients age > 60 with AML/high-risk MDS
about
New designs for phase II trials: application to a trial of targeted therapies vs. chemotherapy in patients age > 60 with AML/high-risk MDS
name
New designs for phase II trial ...... ge > 60 with AML/high-risk MDS
@en
type
label
New designs for phase II trial ...... ge > 60 with AML/high-risk MDS
@en
prefLabel
New designs for phase II trial ...... ge > 60 with AML/high-risk MDS
@en
P1433
P1476
New designs for phase II trial ...... ge > 60 with AML/high-risk MDS
@en
P2093
P356
10.1007/S00277-004-0850-2
P478
83 Suppl 1
P577
2004-01-01T00:00:00Z